LatticeMLS
Menu

Module CC-05 · Version 1.0

Reading an Endocrine Feedback Loop

A stimulating hormone and its target-gland hormone travel together as a pair, not as two independent numbers. The negative-feedback model behind that pair shows how the direction of both values localizes a problem to the target gland versus the pituitary or hypothalamus; timing, binding-protein, illness, and assay-interference factors can make that pattern mislead a reader who has not checked the context behind the numbers.

Your next section

Start section 1

Read without an account. Sign in to save.

Who this module is for

Clinical laboratory scientists and students who release chemistry and immunoassay results and need to read paired endocrine results correctly before escalating or repeating a specimen.

Learning objectives

  • Draw a simple hypothalamic-pituitary-target-gland feedback loop
  • Predict primary, secondary, and tertiary pattern directions
  • Identify timing, pulsatility, binding proteins, medication, acute illness, and assay interference as reasons a simple pattern may fail

How completion works

Mark every required section done and answer every knowledge check in those sections correctly. The final save completes the module automatically.

Sources

16 sources

  1. 1. Nieman LK, Biller BM, Findling JW, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389.

    Source note · professional society guidance

  2. 2. Endocrine Society. Hormone Replacement in Hypopituitarism: A Clinical Practice Guideline. 2016.

    Source note · professional society guidance

  3. 3. American Thyroid Association. Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An ATA-Commissioned Review of Current Clinical and Laboratory Status.

    Source note · professional society guidance

  4. 4. Garber JR, Cobin RH, Gharib H, et al. Clinical Practice Guidelines for Hypothyroidism in Adults, cosponsored by AACE and ATA. Thyroid. 2012;22(12):1200-1235.

    Source note · professional society guidance

  5. 5. American Thyroid Association. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum; ATA patient page, Hypothyroidism in Pregnancy.

    Source note · professional society guidance

  6. 6. U.S. Food and Drug Administration. The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. Nov 28, 2017, updated Nov 5, 2019.

    Source note · federal guidance

  7. 7. U.S. Food and Drug Administration. Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry. October 2020.

    Source note · federal guidance

  8. 8. NCBI Bookshelf/Endotext. Stress: Endocrine Physiology and Pathophysiology. In: Feingold KR, et al., eds. Endotext. NBK278995.

    Source note · peer-reviewed literature

  9. 9. Debono M, Ross RJ, Newell-Price J. Endocrine Testing Protocols: Hypothalamic Pituitary Adrenal Axis. In: Endotext. NBK278940.

    Source note · peer-reviewed literature

  10. 10. Normal Physiology of ACTH and GH Release in the Hypothalamus and Anterior Pituitary in Man. In: Endotext. NBK279116.

    Source note · peer-reviewed literature

  11. 11. Van den Berghe G, et al. (chapter authors). The Non-Thyroidal Illness Syndrome. In: Endotext. NBK285570.

    Source note · peer-reviewed literature

  12. 12. Surks MI, Hollowell JG. Age-Specific Distribution of Serum Thyrotropin and Antithyroid Antibodies in the US Population: Implications for the Prevalence of Subclinical Hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575-4582.

    Source note · peer-reviewed literature

  13. 13. Roche Diagnostics. Elecsys ACTH Method Sheet (Instructions for Use).

    Source note · manufacturer labeling

  14. 14. Code of Federal Regulations. 42 CFR 493.1253, Standard: Establishment and verification of performance specifications.

    Source note · federal guidance

  15. 15. Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, 3rd ed. CLSI document EP28-A3c. Wayne, PA: CLSI; 2010 (reaffirmed 2020).

    Source note · consensus standard

  16. 16. College of American Pathologists. All Common Checklist, COM.40605 Reference Intervals (Phase II). CAP Accreditation Program, 12.09.2025 edition.

    Source note · accreditation standard